Redmile Group LLC 13D/13G Filings for Achilles Therapeutics plc (ACHL)

Redmile Group LLC 13D and 13G filings for Achilles Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-14
4:29 pm
Sale
2022-12-3113GAchilles Therapeutics plc
ACHL
Redmile Group LLC1,608,089
3.900%
-480,000decrease
(-22.99%)
Filing
2022-02-14
5:07 pm
Purchase
2021-12-3113GAchilles Therapeutics plc
ACHL
Redmile Group LLC2,088,089
5.100%
2,088,089increase
(New Position)
Filing